PAVM PAVMED INC Capital Structure Changes 8-K Filing 2025 - Equity Exchange Pavmed Inc. exchanged $22.3 million in convertible notes for 22,347 shares of Series C Preferred Stock to improve its stockholders' equity and comply with Nasdaq listing standards, following a notice of potential delisting due to low market value.Get access to all SEC 8-K filings of the PAVMED INC